Murat, S. Et Al. 2022. Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction. KARDIOLOGIA POLSKA , vol.80, no.6 , 672-678.

Murat, S., Cavusoglu, Y., Yalvac, H. E., Sivrikoz, I. A., & Kocagil, S., (2022). Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction. KARDIOLOGIA POLSKA , vol.80, no.6, 672-678.

Murat, SELDA Et Al. "Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction," KARDIOLOGIA POLSKA , vol.80, no.6, 672-678, 2022

Murat, SELDA Et Al. "Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction." KARDIOLOGIA POLSKA , vol.80, no.6, pp.672-678, 2022

Murat, S. Et Al. (2022) . "Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction." KARDIOLOGIA POLSKA , vol.80, no.6, pp.672-678.

@article{article, author={SELDA MURAT Et Al. }, title={Assessment of clinical characteristics of cardiac amyloidosis as a potential underlying etiology in patients diagnosed with heart failure with preserved ejection fraction}, journal={KARDIOLOGIA POLSKA}, year=2022, pages={672-678} }